Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt

Author:

Barcellini Amelia12ORCID,Fodor Andrei3ORCID,Charalampopoulou Alexandra45ORCID,Cassani Chiara67ORCID,Locati Laura Deborah28,Cioffi Raffaella9ORCID,Bergamini Alice9,Pignata Sandro10ORCID,Orlandi Ester1ORCID,Mangili Giorgia9ORCID

Affiliation:

1. Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy

2. Department of Internal Medicine and Medical Therapy, University of Pavia, 27100 Pavia, Italy

3. Department of Radiation Oncology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy

4. Radiobiology Unit, Research and Development Department, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy

5. Hadron Academy PhD Course, Istituto Universitario di STUDI Superiori (IUSS), 27100 Pavia, Italy

6. Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy

7. Unit of Obstetrics and Gynecology, IRCCS, Fondazione Policlinico San Matteo, 27100 Pavia, Italy

8. Translational Oncology Unit, Maugeri Clinical Research Institutes IRCCS, 27100 Pavia, Italy

9. Unit of Gynaecology and Obstetrics, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy

10. Department of Urology and Gynecology, Istituto Nazionale Tumori, IRCCS-Fondazione G. Pascale Napoli, 80131 Naples, Italy

Abstract

Gestational trophoblastic neoplasia (GTN) includes several rare malignant diseases occurring after pregnancy: invasive moles, choriocarcinoma, placental site trophoblastic tumours, and epithelioid trophoblastic tumours. Multidisciplinary protocols including multi-agent chemotherapy, surgery, and occasionally radiotherapy achieve good outcomes for some high-risk metastatic patients. In this narrative review of the published studies on the topic, we have tried to identify the role of radiotherapy. The available studies are mainly small, old, and retrospective, with incomplete data regarding radiotherapy protocols delivering low doses (which can make this disease appear radioresistant in some cases despite high response rates with palliative doses) to wide fields (whole-brain, whole-liver, etc.), which can increase toxicity. Studies considering modern techniques are needed to overcome these limitations and determine the full potential of radiotherapy beyond its antihemorrhagic and palliative roles.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference92 articles.

1. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Seckl;Ann. Oncol.,2013

2. Diagnosis and management of gestational trophoblastic disease: 2021 update;Ngan;Int. J. Gynaecol. Obstet.,2021

3. Update on the diagnosis and management of gestational trophoblastic disease;Ngan;Int. J. Gynaecol. Obstet.,2018

4. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology;Yashar;J. Natl. Compr. Canc. Netw.,2019

5. (2023, July 27). Guidelines Version 1. 2023 Gestational Trophoblastic Neoplasia. Available online: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1489.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3